Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sonoma Biotherapeutics
Research
How Nobel-winning cells could become a 'universal drug'
With their broad ability to tamp down immune activity, regulatory T cells could potentially be harnessed to treat just about any inflammatory disease.
Darren Incorvaia
Oct 21, 2025 2:00pm
3 scientists win Nobel Prize for discovery of regulatory T cells
Oct 6, 2025 7:03am
Sanofi snags CMO from BioMarin—Chutes & Ladders
Aug 29, 2025 8:30am
Regeneron to take $56M IPR&D hit in Q1
Apr 10, 2023 2:40pm
Biotech's top 10 money raisers of 2021
Apr 18, 2022 3:00am
Sonoma Bio bags $265M for arthritis, diabetes cell therapies
Aug 4, 2021 7:00am
